Drug intelligence / Profile preview

Yishen Huashi Granules

Development stage
Unknown
Lead developer
Consun Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Yishen Huashi Granules is a traditional Chinese medicine (TCM) formula developed and manufactured by Guangzhou Consun Pharmaceutical. It is composed of multiple herbal ingredients including ginseng, astragalus, atractylodes macrocephala, poria cocos, alisma orientale, pinellia ternata (processed), notopterygium root, angelica pubescens root, saposhnikovia divaricata root, bupleurum chinense root, coptis chinensis rhizome, paeonia lactiflora root (white peony), dried tangerine peel (chenpi), honey-fried licorice root (zhigancao), fresh ginger and jujube. The granule is brown with a bitter taste. The main clinical indications are chronic glomerulonephritis with spleen deficiency and dampness syndrome presenting as proteinuria with edema and fatigue. Pharmacological studies show it can reduce proteinuria and serum creatinine in animal models of nephritis; clinical studies suggest it improves renal function markers such as serum creatinine and urea nitrogen in patients with chronic kidney disease or diabetic nephropathy. Its mechanism involves tonifying the kidney and spleen while promoting diuresis to eliminate dampness; recent research also suggests modulation of the gut-kidney axis may play a role in its efficacy for diabetic kidney disease. Yishen Huashi Granules is typically used orally by dissolving one sachet in hot water three times daily for two months per treatment course. It is often used adjunctively with ACE inhibitors or ARBs for enhanced effect on renal outcomes without increasing adverse events[1][2][3][4][5][6].

Brand names
Yishen Huashi Granules
Other names
益肾化湿颗粒yishenhuashikeli

Beyond the preview

Go deeper on Yishen Huashi Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yishen Huashi Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call